Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...
PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...
Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...
This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
This study aimed to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT for prostate cancer patients. The data of...
A 4-room center treating ~90 patients/day, treating for ~7 years underwent a software upgrade which reduced room and energy switching times from ~30 to~20 sec...